OREANDA-NEWS. Hooper Holmes, Inc. (NYSE MKT:HH) today announced financial results for the quarter ended June 30, 2016.

Consolidated revenues totaled $7.6 million for the second quarter of 2016, essentially flat compared to the second quarter of 2015.  The Company recorded a net loss of $2.5 million for the second quarter of 2016 compared to a net loss of $3.4 million for the second quarter of 2015, a 26% improvement.  Adjusted EBITDA for the second quarter 2016 was a loss of $1.1 million, an improvement of approximately 10% compared to the second quarter 2015. 

Gross profit for the 2016 second quarter increased to $1.8 million, compared to $1.7 million for the same period last year.  Selling, general and administrative expense for the three month period ending June 30, 2016, totaled $3.8 million, essentially flat compared to the second quarter of 2015. 

Henry Dubois, President and CEO of Hooper Holmes commented, "We continued to execute our business plan in the first half of the year and lay the groundwork for a strong second half.  Revenue improved 11.5% and gross margin improved 33%, compared to first six months of 2015. We expanded our delivery model in the second quarter through an agreement with MinuteClinic, the walk-in clinic located inside select CVS Pharmacy and Target stores, and by adding onsite flu vaccines and other new services to our product line.  Our delivery model is highly scalable, and as our top line revenues grow we believe we will expand our margins and  increase market share."

 

About Hooper Holmes

Hooper Holmes mobilizes a national network of health professionals to provide on-site health screenings, laboratory testing, risk assessment and sample collection services to wellness and disease management companies, employers and brokers, government organizations and academic institutions nationwide. Under the Accountable Health Solutions brand, the Company combines smart technology, healthcare and behavior change expertise to offer comprehensive health and wellness programs that improve health, increase efficiencies and reduce healthcare delivery costs.

More information is available at hooperholmes.com and at accountablehealthsolutions.com.

This press release contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements may generally be identified by the use of words such as "anticipate," "believe," "expect," "intends," "plan," and "will" or, in each case, their negative, and other variations or comparable terminology.  These forward-looking statements include all statements other than historical facts. Any forward-looking statement made by management during this call is not a guarantee of future performance, and actual results may differ materially from those expressed in or suggested by the forward-looking statements, as a result of various factors, including, without limitation the factors discussed in the “Risk Factors” section of the company’s Annual Report on Form 10-K for the year ended December 31, 2015, as the same may be updated from time-to-time in subsequent filings with the Securities and Exchange Commission. Any forward-looking statement made by management on this call speaks only as of the date hereof, and the Company has no obligation, and does not intend, to update any forward-looking statements after the date hereof, except as required by federal securities laws. In addition, management uses the non-GAAP performance measures EBITDA and Adjusted EBITDA on this call.  You can find a reconciliation of such measures to their nearest GAAP equivalent in the Company’s earnings release, which is available on our website.

Hooper Holmes, Inc.            
Consolidated Balance Sheets            
(in thousands)              
                   
            June 30, 2016   December 31, 2015  
ASSETS       (unaudited)      
Current assets:              
  Cash and cash equivalents     $   102     $   2,035    
  Accounts receivable, net of allowance for doubtful accounts       5,376         5,565    
  Inventories           981         567    
  Other current assets         319         331    
    Total current assets         6,778         8,498    
                   
Property, plant and equipment, net         2,134         2,771    
Intangible assets, net           4,681         5,331    
Goodwill           633         633    
Other assets           402         450    
    Total assets           14,628         17,683    
                   
LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY          
Current liabilities:              
  Accounts payable           4,734         5,339    
  Accrued expenses           4,685         5,186    
  Short-term debt           5,142         5,330    
  Total current liabilities         14,561         15,855    
                   
Other long term liabilities         544         1,611    
                   
Commitments and contingencies            
                   
Stockholders' (deficit) equity:            
  Common stock           349         3,121    
  Additional paid-in capital         164,089         156,195    
  Accumulated deficit         (164,915 )       (159,028 )  
                (477 )       288    
  Less: Treasury stock at cost         -         (71 )  
  Total stockholders' (deficit) equity         (477 )       217    
    Total liabilities and stockholders' (deficit) equity   $   14,628     $   17,683    
                   
                     
HOOPER HOLMES INC.                  
CONSOLIDATED STATEMENTS OF OPERATIONS                  
(unaudited; in thousands, except share and per share data)                  
                     
                     
                     
      Three months ended June 30,   Six months ended June 30,  
        2016       2015       2016       2015    
                     
Revenues   $   7,643     $   7,662     $   14,884     $   13,343    
Cost of operations       5,878         5,969         11,659         10,918    
  Gross profit       1,765         1,693         3,225         2,425    
Selling, general and administrative expenses       3,724         3,811         7,551         6,471    
Transaction costs       221         593         329         679    
  Operating loss from continuing operations       (2,180 )       (2,711 )       (4,655 )       (4,725 )  
Interest expense, net       1,011         626         1,800         709    
Other income       (887 )       -         (887 )       -    
  Loss from continuing operations before taxes        (2,304 )       (3,337 )       (5,568 )       (5,434 )  
Income tax expense       5         5         10         10    
  Loss from continuing operations        (2,309 )       (3,342 )       (5,578 )       (5,444 )  
                     
Discontinued operations:                  
  Loss from discontinued operations       (150 )       (21 )       (309 )       (25 )  
Net loss   $   (2,459 )   $   (3,363 )   $   (5,887 )   $   (5,469 )  
                     
Reconciliation of GAAP results to Non-GAAP results                  
  Interest expense   $   225     $   158     $   438     $   158    
  Other debt related costs included in interest expense       786         468         1,362         551    
  Income tax expense       5         5         10         10    
  Depreciation and amortization       708         580         1,409         873    
  Share-based compensation expense       390         103         470         193    
  Stock payments       (100 )       -         50         -    
  Transaction costs       221         593         329         679    
  Transition costs       2         258         54         258    
  Portamedic contingent liability       -         -         150         -    
  Write-off of Additional Warrant       (887 )       -         (887 )       -    
Adjusted (Non-GAAP) EBITDA   $   (1,109 )   $   (1,198 )   $   (2,502 )   $   (2,747 )  
                     
Adjusted EBITDA for second quarter 2016 was ($1.1 million), compared to ($1.2 million) of adjusted EBITDA in the second quarter of 2016. The above
schedule is a description of adjustments made to net loss.		  
 
                     
Income (loss) per share                  
  Continuing operations:                  
    Basic   $   (0.27 )   $   (0.65 )   $   (0.67 )   $   (1.10 )  
    Diluted       (0.27 )       (0.65 )       (0.67 )       (1.10 )  
  Discontinued operations:                  
    Basic       (0.02 )       (0.00 )       (0.04 )       (0.01 )  
    Diluted       (0.02 )       (0.00 )       (0.04 )       (0.01 )  
  Net loss:                  
    Basic       (0.29 )       (0.65 )       (0.71 )       (1.11 )  
    Diluted       (0.29 )       (0.65 )       (0.71 )       (1.11 )  
                     
Weighted average number of shares:                   
  Basic and diluted     8,602,590       5,162,786       8,329,568       4,944,824